MG
TNYA icon

Marex Group’s Tenaya Therapeutics TNYA Stock Holding History

Marex Group’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$174K Hold
235,500
– – ﹤0.01% 1028
2026
Q1 		$163K Buy
235,500
+50,489
+27% +$37.3K ﹤0.01% 920
2025
Q4 		$132K Sell
185,011
-117,489
-39% -$160K ﹤0.01% 886
2025
Q3 		$490K Sell
302,500
-110,000
-27% -$111K ﹤0.01% 503
2025
Q2 		$252K Hold
412,500
– – ﹤0.01% 483
2025
Q1 		$235K Buy
412,500
+150,000
+57% +$148K ﹤0.01% 538
2024
Q4 		$375K Buy
+262,500
New +$588K 0.01% 411

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group's TNYA Position: Q2 2026 in Review

Marex Group held its Tenaya Therapeutics (TNYA) position steady in Q2 2026 at 235,500 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #1028.

Marex Group first reported a position in TNYA in Q4 2024 and has held it in 7 quarters since. The position peaked at $490K in Q3 2025. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Marex Group held 235,500 shares of Tenaya Therapeutics worth $174K as of Q2 2026.
  • Marex Group left its Tenaya Therapeutics share count unchanged in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #1028 holding.
  • Marex Group first reported a position in Tenaya Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Marex Group's Tenaya Therapeutics position peaked at $490K in Q3 2025.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.